El mercado de medición de creatinina fue valorado en 384,69 millones de dólares en 2019 y se prevé que alcance los 705,96 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 8,0% de 2020 a 2027.
Las pruebas de medición de creatinina se realizan con el objetivo de analizar el funcionamiento de los riñones. Estas pruebas pueden ofrecer información completa sobre el nivel de enfermedad renal crónica y el riesgo de insuficiencia renal. Además, los niveles más altos de creatinina en sangre se atribuyen a la obstrucción renal, la deshidratación, el aumento del consumo de proteínas y el consumo excesivo de medicamentos. Algunos de los productos de medición de creatinina comprenden kits y reactivos. El crecimiento del mercado mundial de medición de creatinina se atribuye a la creciente prevalencia de enfermedades renales crónicas y al aumento de la población geriátrica. Sin embargo, el cambio hacia la adopción de nuevos biomarcadores es el principal factor que obstaculiza el crecimiento del mercado.
Se espera que el mercado mundial de medición de creatinina sea testigo de un crecimiento sustancial después de la pandemia. El COVID-19 ha afectado a las economías e industrias de varios países debido a cierres, prohibiciones de viaje y cierres de empresas. La crisis de la COVID-19 ha sobrecargado los sistemas de salud pública en muchos países y ha puesto de relieve la gran necesidad de realizar inversiones sostenibles en los sistemas de salud. A medida que avanza la pandemia de COVID-19, se espera que la industria de la salud experimente una caída en su crecimiento. El segmento de ciencias biológicas prospera debido a la mayor demanda de productos de diagnóstico in vitro y al aumento de las actividades de investigación y desarrollo en todo el mundo. Sin embargo, el segmento de tecnologías médicas e imágenes está experimentando una caída en las ventas debido a un menor número de cirugías realizadas y a retrasos o prolongaciones en la adquisición de equipos. Además, se espera que las consultas virtuales realizadas por profesionales de la salud se conviertan en el modelo principal de prestación de atención después de la pandemia. Dado que la telesalud está transformando la prestación de atención, la salud digital seguirá prosperando en los próximos años. Además, también se espera que la interrupción de los ensayos clínicos y el consiguiente retraso en el lanzamiento de medicamentos allanen el camino para ensayos totalmente virtuales en el futuro. Se espera que surjan nuevas tecnologías como el ARNm y que cambien la industria farmacéutica y también se espera que el mercado sea testigo de una mayor integración vertical y empresas conjuntas en los próximos años.
regiones lucrativas para el mercado global de medición de creatinina
Perspectivas del mercado< /h3>Aumento de la prevalencia de trastornos renales crónicos para impulsar el crecimiento del mercado mundial de medición de creatinina
Según la Fundación Nacional del Riñón, la prevalencia mundial de la enfermedad renal crónica (ERC) está aumentando. Alrededor del 10% de la población mundial se ve afectada por la ERC y millones mueren cada año porque no tienen acceso a un tratamiento asequible. Más de 2 millones de personas afectadas reciben tratamiento mediante diálisis o trasplante de riñón. La mayoría recibe tratamiento en sólo cinco países desarrollados: Estados Unidos, Japón, Alemania, Brasil e Italia. Estos cinco países desarrollados atienden sólo al 12% de la población mundial. Según el estudio Global Burden of Disease de 2010, las enfermedades renales crónicas ocupaban el puesto 27 en 1990, pero ascendieron al puesto 18 en 2010 en cuanto a tasa de mortalidad.
Debido a la La creciente prevalencia de enfermedades renales crónicas entre las masas es ampliamente reconocida como un problema de salud mundial. Según la Sociedad Estadounidense de Nefrología (ASN), existen avances recientes en curso en el diagnóstico molecular que están abriendo formas de tratar a los pacientes que padecen trastornos relacionados con los riñones. Avances como la amplificación y detección de ácidos nucleicos, la proteómica, el análisis genómico y la metabolómica han permitido realizar varios ensayos de diagnóstico molecular. Además, la medición de la concentración de creatinina en suero o plasma se ha utilizado ampliamente en química clínica para evaluar el funcionamiento de los riñones. Según las etapas de la ERC, los niveles de creatinina pueden proporcionar un análisis completo de los riñones. La tasa de filtración glomerular, base esencial para la identificación de la enfermedad renal crónica, está determinada por el marcador de creatinina. Debido a su eficacia para el análisis de la función renal, las directrices para mejorar los resultados globales de la enfermedad renal (KDIGO) recomendaron el uso de la medición de creatinina para el cribado renal en 2012. Por lo tanto, el aumento de los trastornos renales crónicos junto con los beneficios de la medición de creatinina para comprender el estado de los riñones Es probable que aumente la demanda de dispositivos de medición de creatinina durante el período de pronóstico.
Información basada en el producto
En términos de producto, el nivel global de creatinina El mercado de medición se segmenta en kits y reactivos. En 2019, el segmento de reactivos tuvo la mayor participación del mercado. Además, se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
Mercado global de medición de creatinina, por producto: 2019 y 2027
Información basada en el tipo
Según el tipo, la medición global de creatinina El mercado se segmenta en método enzimático y método cinético de Jaffe. El segmento del Método Cinético de Jaffe tuvo la mayor participación de mercado en 2019. Además, se estima que el mismo segmento crecerá al ritmo más rápido durante el período de pronóstico.
Muestra Información basada en el tipo
Según el tipo de muestra, el mercado global de medición de creatinina se segmenta en sangre o suero, orina y otros. El segmento de sangre o suero tuvo la mayor participación de mercado en 2019. Además, se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
; ; ; ;
Información basada en el usuario final
En términos de usuario final, el mercado global de medición de creatinina está segmentado en hospitales, laboratorios de diagnóstico y otros. El segmento de laboratorios de diagnóstico tuvo la mayor participación de mercado en 2019, y se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
Perspectivas estratégicas
Los actores del mercado global de medición de creatinina están adoptando estrategias de expansión y lanzamiento de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
Mercado global de medición de creatinina: por producto
- Reactivos
- Kits
Mercado global de medición de creatinina: por tipo
- Método cinético de Jaffe
- Método enzimático
Mercado global de medición de creatinina: por tipo de muestra
- Sangre o plasma
- Orina
Mercado global de medición de creatinina: por usuario final
- Hospitales
- Laboratorios de diagnóstico
- Otros
Mercado global de medición de creatinina: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- Suramérica y Centroamérica (SCAM)
- Brasil
- Argentina
- Resto de SCAM
< /ul> - Siemens Healthcare Gmbh
- Abbott
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Danaher (Beckman Coulter)
- Cayman Chemical
- Randox Laboratories Ltd
- Fujifilm Wako Pure Chemical Corporation
- Bioquímica Leadman de Beijing
- Shanghai Fosun Pharmaceutical Group Co., Ltd
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Beijing fuerte Biotechnologies, Inc. (Bsbe)
- Diazyme Laboratories, Inc
- Dialab Gmbh
- Maccura Biotechnology Co., Ltd.
Perfiles de empresas
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Creatinine measurement tests are performed with an aim to analyze functioning of kidneys. These tests can offer comprehensive information about level of chronic kidney disease and risk of renal failure. Furthermore, higher levels of creatinine in the blood are attributed to kidney obstruction, dehydration, increased consumption of proteins, and excessive consumption of medications.
Increasing prevalence of chronic kidney disorders coupled, benefits of creatinine measurement to understand the condition of kidneys, and growing prevalence of CKD among the geriatric population are expected to boost the market growth over the years. Moreover, emerging markets in developing countries is likely to have a positive impact on the growth of the market in coming years.
Depending upon the location of patients and laboratories, cost of creatinine varies. The serum creatinine blood test costs around US$ 25, while the creatinine clearance urine test can cost from US$ 35 to US$ 65.
The List of Companies - Creatinine Measurement Market
- Siemens Healthcare Gmbh
- Abbott
- Cayman Chemical
- Thermo Fisher Scientific Inc.
- Fujifilm Wako Pure Chemical Corporation
- Randox Laboratories Ltd
- F. Hoffmann-La Roche Ltd
- Danaher (Beckman Coulter)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Maccura Biotechnology Co., Ltd.
- Diazyme Laboratories, Inc
- Dialab Gmbh
- Beijing Strong Biotechnologies, Inc. (Bsbe)
- Beijing Leadman Biochemistry
- Fosun Pharmaceutical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)